Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member.

Regency Centers Corporation

Regis Healthcare Ltd. ( ($AU:REG) ) has provided an update. Regis Healthcare has announced that director Linda Jane Mellors ceased to be a director...

Regis Healthcare Discloses Final Director Interest as Linda Mellors Exits Board

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. The study titled “A FIH Phase 1/2 Study to Assess Safety, To...

Regeneron Advances First-in-Human Myeloma Combo Trial, Keeping Oncology Pipeline in Focus

The latest update is out from Regeneron ( ($REGN) ). At its 2026 Annual Meeting of Shareholders held on June 12, 2026, Regeneron shareholders elect...

Regeneron Shareholders Back Directors, Auditor and Executive Pay

RemeGen Co. Ltd. Class H ( ($HK:9995) ) has provided an update. RemeGen Co., Ltd. held its 2025 annual general meeting in Yantai, with shareholders...

RemeGen Shareholders Back All Resolutions at 2025 AGM

The latest announcement is out from RemeGen Co. Ltd. Class H ( ($HK:9995) ). RemeGen Co., Ltd. has disclosed the current composition of its board o...

RemeGen Clarifies Board Composition and Committee Roles

Creactives Group S.p.A. ( ($IT:CREG) ) has shared an update. Creactives Group S.p.A., an AI-driven supply chain software provider listed on Euronex...

Creactives to Present Strategy at Pan-European Mid & Small Virtual 2026 Conference

Let’s take a look at the upcoming stock splits for the week of June 15 to June 18, based on TipRanks’ Stock Splits Calendar. Stock splits are among...

Upcoming Stock Splits This Week (June 15 to June 18) – Stay Invested

Analysts have been eager to weigh in on the Real Estate sector with new ratings on National Health Investors (NHI), RLJ Lodging (RLJ) and Regency C...

Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI), RLJ Lodging (RLJ) and Regency Centers (REG)

J.P. Morgan analyst Yang Huang maintained a Buy rating on RemeGen Co. Ltd. Class H on June 9 and set a price target of HK$129.00. The company’s sha...

J.P. Morgan Sticks to Their Buy Rating for RemeGen Co. Ltd. Class H (9995)

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. The study A Randomized, Open-Label, Dose-Ranging Study to Ev...

Regeneron Tests Weekly Praluent Dosing in New Cholesterol Study: What Investors Should Watch

In a report released on June 8, from UBS maintained a Buy rating on RemeGen Co. Ltd. Class H, with a price target of HK$141.10. The company’s share...

RemeGen Co. Ltd. Class H (9995) Gets a Buy from UBS

RemeGen Co. Ltd. Class H ( ($HK:9995) ) just unveiled an announcement. RemeGen has secured conditional marketing approval from China’s National Med...

RemeGen Wins Conditional China Nod for Telitacicept in IgA Nephropathy

Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The RAPID registry from Regeneron and Sanof...

RAPID Real‑World Dupixent Data Could Extend Regeneron and Sanofi’s Asthma Edge

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron’s CLIO-1 trial, officially titled “A Phase 1 Study...

Regeneron’s CLIO-1 Update: What a Completed Early Lymphoma Trial Means for REGN Investors

Regency Centers ( ($REG) ) just unveiled an announcement. On June 1, 2026, Regency Centers Corporation released an updated investor presentation fo...

Regency Centers Updates Investor Presentation and Outlook Materials

Regency Centers ( ($REG) ) just unveiled an update. On June 1, 2026, Regency Centers Corporation released an updated investor presentation for use ...

Regency Centers Updates Investor Presentation to Enhance Transparency

In a report released on May 28, from Morgan Stanley maintained a Hold rating on RemeGen Co. Ltd. Class H, with a price target of HK$98.00. The comp...

Morgan Stanley Keeps Their Hold Rating on RemeGen Co. Ltd. Class H (9995)

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. The Phase 1, open-label study titled “A Phase 1, Open-Label,...

Regeneron Steps Into CAR T for Advanced Prostate Cancer With New Phase 1 Trial

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is running a mid-stage trial calle...

Regeneron Expands Into Pulmonary Hypertension With New Phase 2 Trial for REGN13335

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is running a late-stage study call...

Regeneron Targets Stroke Prevention Gap With New Atrial Fibrillation Trial

In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Regency Centers, with a price target of $84.00. Accordin...

Truist Financial Keeps Their Buy Rating on Regency Centers (REG)

Regency Centers ( ($REG) ) has shared an update. On May 28, 2026, Regency Centers released its 2025 Corporate Responsibility Report, emphasizing th...

Regency Centers Highlights 2025 Corporate Responsibility Progress

Regency Centers ( ($REG) ) has provided an update. On May 28, 2026, Jacksonville-based Regency Centers released its 2025 Corporate Responsibility R...

Regency Centers Highlights Sustainability in 2025 Responsibility Report

The latest announcement is out from Regency Centers ( ($REG) ). On May 27, 2026, Regency Centers Corporation released an updated investor presentat...

Regency Centers Updates Investor Presentation for Shareholders

An announcement from Regency Centers ( ($REG) ) is now available. On May 27, 2026, Regency Centers Corporation released an updated investor present...

RBC Capital analyst Craig Wong-Pan upgraded Regis Healthcare Ltd. to a Buy on May 25 and set a price target of A$7.50. The company’s shares closed ...

Regis Healthcare Ltd. (REG) was upgraded to a Buy Rating at RBC Capital

The latest update is out from RemeGen Co. Ltd. Class H ( ($HK:9995) ). RemeGen Co., Ltd. has been actively deploying part of its idle self-owned fu...

RemeGen Expands Use of Idle Funds in HTSC Wealth Products

Analysts are intrested in these 5 stocks: ( ($REGN) ), ( ($CRCL) ), ( ($BURL) ), ( ($ROST) ) and ( ($PBA) ). Here is a breakdown of their recent


Regeneron, Circle, Burlington, Ross, Pembina Trending With Analysts

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Merck & Company (MRK) with bull...

Current Quarter	$1.2	Next Quarter	$1.22
Current Year	$4.85	Next Year	$5.09
QoQ Growth	+1.7%	YoY Growth	+4.9%
3Y EPS CAGR	+0.0%	Target Price	$84.05
Consensus	Buy	Upside	+9.3%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	REG	$76.88	-0.63%	1.67M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	REG	$76.88	-0.6%	1.67M
3
4
5
6

REG

REG

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Regency Centers Corporation Data in Excel

Get Regency Centers Corporation Data in Excel